Intra-Cellular Therapies: Number of Employees 2013-2022 | ITCI

Interactive chart of Intra-Cellular Therapies (ITCI) annual worldwide employee count from 2013 to 2022.
  • Intra-Cellular Therapies total number of employees in 2021 was 512, a 33.68% increase from 2020.
  • Intra-Cellular Therapies total number of employees in 2020 was 383, a 16.06% increase from 2019.
  • Intra-Cellular Therapies total number of employees in 2019 was 330, a 352.05% increase from 2018.
  • Intra-Cellular Therapies total number of employees in 2018 was 73, a 48.98% increase from 2017.
Intra-Cellular Therapies Annual Number of Employees
2021 512
2020 383
2019 330
2018 73
2017 49
2016 42
2015 39
2014 51
2013 22
2012 21
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $5.204B $0.084B
Intra-Cellular Therapies Inc. is a biopharmaceutical company. The company develops drugs for the treatment of neuropsychiatric and neurologic diseases and other disorders of the central nervous system. Its product candidates include ITI-007, ITI-002 and ITI-009 which is in clinical trials. Intra-Cellular Therapies Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $163.597B 9.95
Bio-Rad Laboratories (BIO.B) United States $14.907B 32.33
QIAGEN (QGEN) Netherlands $10.865B 17.15
Biohaven Pharmaceutical Holding (BHVN) United States $10.248B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.228B 0.00
Arcus Biosciences (RCUS) United States $1.901B 48.18
Emergent Biosolutions (EBS) United States $1.599B 6.85
Myovant Sciences (MYOV) United Kingdom $1.236B 0.00
Zymeworks (ZYME) Canada $0.320B 0.00
Gelesis Holdings (GLS) United States $0.114B 0.00
Enzo Biochem (ENZ) United States $0.104B 0.00
Ambrx Biopharma (AMAM) United States $0.103B 0.00
SQZ Biotechnologies (SQZ) United States $0.087B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00